Therefore, we performed a study on the expression of CD103 in basal cell carcinomas and squamous cell carcinomas of the skin following approval by the ethics committee of the University Medical Center Göttingen (no. 19/3/17). The gene discussed is ITGAE; the disease is basal cell carcinoma.